Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Gemcitabine
Docetaxel
+6 more
Locations
2
United States
University of Texas MD Anderson Cancer Center
Houston, Texas, United States
Fred Hutchinson Cancer Center
Seattle, Washington, United States
Start Date
June 2, 2009
Primary Completion Date
January 11, 2024
Completion Date
January 11, 2024
Last Updated
August 26, 2024
NCT07218913
NCT07106827
NCT06814496
NCT06954233
NCT06673329
NCT04435756
Lead Sponsor
M.D. Anderson Cancer Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions